BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

CUSIP: G11217125

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / *W EXP 12/02/202
Total 13F shares
7,658,459
Share change
+155,541
Total reported value
$429,338
Price per share
$0.06
Number of holders
41
Value change
-$4,118
Number of buys
9
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) as of Q3 2023

As of 30 Sep 2023, BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,658,459 shares. The largest 10 holders included Periscope Capital Inc., Polar Asset Management Partners Inc., Shaolin Capital Management LLC, COWEN AND COMPANY, LLC, Calamos Advisors LLC, GOLDMAN SACHS GROUP INC, MMCAP International Inc. SPC, AQR Arbitrage LLC, D. E. Shaw & Co., Inc., and Cubist Systematic Strategies, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.